[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/MONDO_0005452",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/MONDO_0005452"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://go.drugbank.com/drugs/DB01255"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Of relevance, lisdexamfetamine dimesylate, a psy- chostimulant approved for the treatment of ADHD, has been recently assessed and approved for the treat- ment of moderate to severe binge eating disorder in adults.5,6 In a phase 2 efficacy and safety trial, pa- tients with binge eating disorder who were prescribed doses of 50 and 70 mg/day doses of lisdexamfetamine demonstrated reduced binge eating days per week, greater binge eating cessation rates, and greater rates of clinical global improvement at 11 weeks compared with the placebo control group"
    } ],
    "https://w3id.org/biolink/vocab/association_type" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/has_population_context" : [ {
      "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#cohort"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/publications" : [ {
      "@id" : "https://pubmed.ncbi.nlm.nih.gov/28111772/"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://w3id.org/um/neurodkg/OffLabelIndication"
    } ]
  }, {
    "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#cohort",
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Adults"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Cohort"
    } ]
  }, {
    "@id" : "https://go.drugbank.com/drugs/DB01255",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-7641-6446"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-05-31T10:56:11.922+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-7641-6446"
    } ],
    "http://purl.org/nanopub/x/supersedes" : [ {
      "@id" : "http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    }, {
      "@id" : "http://purl.org/np/RAjpBMlw3owYhJUBo3DtsuDlXsNAJ8cnGeWAutDVjuAuI"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs"
    } ]
  }, {
    "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "YphypbfC5MLmGaLEX3C5eL9995BcWUP86gvXFkkwD0XlZmDJcmtp0GpkmpeDbzjqR/fny0QBUkDyUCcZzYhHgA5gBgFQIYEV1T4NzbemJsJZ5NIhTypa2rGyC1MMbhga0JB9TxMfO734nihy/R42KQnJXMM0TxXK41nYYb+ls1M="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#pubinfo"
} ]